Bioline Rx Ltd ADR (NASDAQ: BLRX)’s Stock Is Down -72.15% Since The Beginning Of The Year, Likely To Sustain The Trend In 2024
During the last session, Bioline Rx Ltd ADR (NASDAQ:BLRX)’s traded shares were 0.67 million, with the beta value of the company hitting 1.48. At the